Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.
about
Innovative clinical trial design for pediatric therapeuticsDaptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsDaptomycin in paediatrics: current knowledge and the need for future researchPharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.Pharmacokinetics and tolerability of single-dose daptomycin in young infantsCommunity-associated Staphylococcus aureus infections in children.Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin.Current use of daptomycin in cardiac surgery and postoperative intensive care.Treatment option for sepsis in children in the era of antibiotic resistance.Dosing antibiotics in neonates: review of the pharmacokinetic data.Clinical Effectiveness, Safety Profile, and Pharmacokinetics of Daptomycin in Pediatric Patients: A Systematic Review.Clinical Experience with Daptomycin in Pediatrics.The Use of Daptomycin to Treat Methicillin-Resistant Staphylococcus Epidermidis Bacteremia in a Critically Ill Child with Renal Failure.Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen.The Use of Daptomycin and Linezolid to Treat Vancomycin-Intermediate Staphylococcus haemolyticus Infection in a Premature Infant.Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults.
P2860
Q24635308-876BF581-2725-467B-A526-B45BD8A142BEQ26752922-0C2583A4-691C-4A38-A39B-9C28EAA55CBDQ27006038-5934449B-2284-4EA2-AB4B-05F54943EFB3Q33657212-F6D4D09D-D89C-40C9-9514-6073465B9687Q34157657-33BAED3F-F273-4473-ABBC-9645797A97E7Q35959546-16431C8A-9529-4690-AD19-AFC763CAFEBBQ36170118-08CD48BF-EE4C-47E5-85C0-F43BFDA7F802Q37747396-64B000EC-76BF-4822-AF05-B649E044CE5FQ37900838-E9359A18-B80A-43AB-9B05-5E0881BC3874Q38086339-728CAA6D-9C90-4DA3-8048-FE74930925B9Q38246118-2EA7F619-2483-4A84-AF35-217824F0BE3BQ38649419-B7273E78-AE45-439F-9844-0806473E060DQ38828204-D5274762-EE43-40CB-AC50-BD83D36E9D17Q39015261-F6FAF8C6-5607-412F-A24C-60D3BB4F11DAQ41455421-9D01A610-D800-48A5-AF99-9C4671CAAE12Q41880058-FD3B0789-ACE2-4176-B63E-A2613FB7D1F0Q41990854-DED996EB-2380-434A-9C2D-9D583A15CFD5Q48197188-EBA68E84-CD4C-493A-BDC1-8E11371B4F09
P2860
Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Single-dose pharmacokinetics o ...... oved gram-positive infections.
@en
Single-dose pharmacokinetics o ...... oved gram-positive infections.
@nl
type
label
Single-dose pharmacokinetics o ...... oved gram-positive infections.
@en
Single-dose pharmacokinetics o ...... oved gram-positive infections.
@nl
prefLabel
Single-dose pharmacokinetics o ...... oved gram-positive infections.
@en
Single-dose pharmacokinetics o ...... oved gram-positive infections.
@nl
P2093
P1476
Single-dose pharmacokinetics o ...... roved gram-positive infections
@en
P2093
David P Benziger
Erica Fischer Hong
Gregory L Kearns
Richard F Jacobs
Susan M Abdel-Rahman
P304
P356
10.1097/INF.0B013E318160EDFC
P50
P577
2008-04-01T00:00:00Z